Form D · Biotechnology
Biocurity, Inc.
New Smyrna Beach, FL · CIK 0001515777
Offering snapshot reported Apr 4, 2012 · SEC filing
- Reported sold
- $135K Offering amount: $1.37M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- Mar 16, 2011 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 4, 2012 | Amendment | $135,000 | $0vs Mar 22, 2011 | 1 | SEC filing |
| Mar 22, 2011 | Initial | $135,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-157132
Source: Form D, filed Apr 4, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Cheryl H. Baker | Director, Executive |
| Kirstie L. Chadwick | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:New Smyrna Beach, FL, 32169